Qvt Fund V Lp - Net Worth and Insider Trading
Qvt Fund V Lp Net Worth
The estimated net worth of Qvt Fund V Lp is at least $1.5 Billion dollars as of 2024-09-20. Qvt Fund V Lp is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Qvt Fund V Lp is the 10% Owner of Urovant Sciences Ltd and owns about 22,703,669 shares of Urovant Sciences Ltd (UROV) stock worth over $369 Million. Qvt Fund V Lp is also the 10% Owner of Sio Gene Therapies Inc and owns about 11,160,714 shares of Sio Gene Therapies Inc (SIOX) stock worth over $5 Million. Details can be seen in Qvt Fund V Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Qvt Fund V Lp has not made any transactions after 2019-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Qvt Fund V Lp
Qvt Fund V Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Qvt Fund V Lp owns 7 companies in total, including Arbutus Biopharma Corp (ABUS) , Myovant Sciences Ltd (MYOV) , and Urovant Sciences Ltd (UROV) among others .
Click here to see the complete history of Qvt Fund V Lp’s form 4 insider trades.
Insider Ownership Summary of Qvt Fund V Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2016-07-08 | director & 10 percent owner & other: See Remarks |
| MYOV | Myovant Sciences Ltd | 2019-06-04 | director & 10 percent owner & other: See remarks |
| UROV | Urovant Sciences Ltd | 2018-10-01 | 10 percent owner |
 | | 2018-06-05 | 10 percent owner |
| | 2014-02-05 | 10 percent owner |
| | 2014-02-19 | 10 percent owner |
| | 2013-09-30 | 10 percent owner |
Qvt Fund V Lp Latest Holdings Summary
Qvt Fund V Lp currently owns a total of 3 stocks. Among these stocks, Qvt Fund V Lp owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 74.62%. Qvt Fund V Lp owns 22,703,669 shares of Urovant Sciences Ltd (UROV) as of October 1, 2018, with a value of $369 Million and a weighting of 25.02%. Qvt Fund V Lp also owns 11,160,714 shares of Sio Gene Therapies Inc (SIOX) as of June 5, 2018, with a value of $5 Million and a weighting of 0.36%.
Latest Holdings of Qvt Fund V Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
| UROV | Urovant Sciences Ltd | 2018-10-01 | 22,703,669 | 16.24 | 368,707,585 |
| SIOX | Sio Gene Therapies Inc | 2018-06-05 | 11,160,714 | 0.48 | 5,334,821 |
Holding Weightings of Qvt Fund V Lp
Qvt Fund V Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Qvt Fund V Lp has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Qvt Fund V Lp around $20 Million.
According to the SEC Form 4 filings, Qvt Fund V Lp has made a total of 0 transactions in Urovant Sciences Ltd (UROV) over the past 5 years. The most-recent trade in Urovant Sciences Ltd is the acquisition of 2,678,571 shares on October 1, 2018, which cost Qvt Fund V Lp around $38 Million.
According to the SEC Form 4 filings, Qvt Fund V Lp has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 1,785,714 shares on June 5, 2018, which cost Qvt Fund V Lp around $25 Million.
Insider Trading History of Qvt Fund V Lp
- 1
Qvt Fund V Lp Trading Performance
GuruFocus tracks the stock performance after each of Qvt Fund V Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Qvt Fund V Lp is -0.99%. GuruFocus also compares Qvt Fund V Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Qvt Fund V Lp within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Qvt Fund V Lp's insider trading performs compared to the benchmark.
Performance of Qvt Fund V Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.34 | | | | | |
| Relative Return to S&P 500(%) | 3.79 | | | | | |
Qvt Fund V Lp Ownership Network
Qvt Fund V Lp Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Qvt Fund V Lp is the director & 10 percent owner & other: See Remarks of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Qvt Fund V Lp made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Qvt Fund V Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Qvt Fund V Lp. You might contact Qvt Fund V Lp via mailing address: 1177 Avenue Of The Americas, 9th Floor, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
